BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 34321607)

  • 1. The RNA-binding protein IGF2BP3 is critical for MLL-AF4-mediated leukemogenesis.
    Tran TM; Philipp J; Bassi JS; Nibber N; Draper JM; Lin TL; Palanichamy JK; Jaiswal AK; Silva O; Paing M; King J; Katzman S; Sanford JR; Rao DS
    Leukemia; 2022 Jan; 36(1):68-79. PubMed ID: 34321607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting IGF2BP3 enhances antileukemic effects of menin-MLL inhibition in MLL-AF4 leukemia.
    Lin TL; Jaiswal AK; Ritter AJ; Reppas J; Tran TM; Neeb ZT; Katzman S; Thaxton ML; Cohen A; Sanford JR; Rao DS
    Blood Adv; 2024 Jan; 8(2):261-275. PubMed ID: 38048400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MBNL1 regulates essential alternative RNA splicing patterns in MLL-rearranged leukemia.
    Itskovich SS; Gurunathan A; Clark J; Burwinkel M; Wunderlich M; Berger MR; Kulkarni A; Chetal K; Venkatasubramanian M; Salomonis N; Kumar AR; Lee LH
    Nat Commun; 2020 May; 11(1):2369. PubMed ID: 32398749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. t(4;11) leukemias display addiction to MLL-AF4 but not to AF4-MLL.
    Kumar AR; Yao Q; Li Q; Sam TA; Kersey JH
    Leuk Res; 2011 Mar; 35(3):305-9. PubMed ID: 20869771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The AF4.MLL fusion protein is capable of inducing ALL in mice without requirement of MLL.AF4.
    Bursen A; Schwabe K; Rüster B; Henschler R; Ruthardt M; Dingermann T; Marschalek R
    Blood; 2010 Apr; 115(17):3570-9. PubMed ID: 20194896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. circRNA circAF4 functions as an oncogene to regulate MLL-AF4 fusion protein expression and inhibit MLL leukemia progression.
    Huang W; Fang K; Chen TQ; Zeng ZC; Sun YM; Han C; Sun LY; Chen ZH; Yang QQ; Pan Q; Luo XQ; Wang WT; Chen YQ
    J Hematol Oncol; 2019 Oct; 12(1):103. PubMed ID: 31623653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tet1 is not required for myeloid leukemogenesis by MLL-ENL in novel mouse models.
    Ono R; Masuya M; Inoue N; Shinmei M; Ishii S; Maegawa Y; Maharjan BD; Katayama N; Nosaka T
    PLoS One; 2021; 16(3):e0248425. PubMed ID: 33705482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-130b and miR-128a are essential lineage-specific codrivers of t(4;11) MLL-AF4 acute leukemia.
    Malouf C; Antunes ETB; O'Dwyer M; Jakobczyk H; Sahm F; Landua SL; Anderson RA; Soufi A; Halsey C; Ottersbach K
    Blood; 2021 Nov; 138(21):2066-2092. PubMed ID: 34111240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SIRT2 regulates proliferation and chemotherapy response of MLL-ENL-driven acute myeloid leukemia.
    Hao C; Shao X; Song J; Peng M; Lao Y; Mack R; Zhang L; Wei W; Liu N; Wang T; Wu Y; Feng L; Yin L; Wang S; Sun X; Chen S; Zhang J; Li B
    Biochem Biophys Res Commun; 2022 Mar; 596():36-42. PubMed ID: 35108652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HBO1-MLL interaction promotes AF4/ENL/P-TEFb-mediated leukemogenesis.
    Takahashi S; Kanai A; Okuda H; Miyamoto R; Komata Y; Kawamura T; Matsui H; Inaba T; Takaori-Kondo A; Yokoyama A
    Elife; 2021 Aug; 10():. PubMed ID: 34431785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ets1 Plays a Critical Role in MLL/EB1-Mediated Leukemic Transformation in a Mouse Bone Marrow Transplantation Model.
    Fu JF; Yen TH; Huang YJ; Shih LY
    Neoplasia; 2019 May; 21(5):469-481. PubMed ID: 30974389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of a rare MLL-AF4 (MLL-AFF1) fusion rearrangement in infant leukemia.
    Bizarro S; Cerveira N; Correia C; Lisboa S; Peixoto A; Norton L; Teixeira MR
    Cancer Genet Cytogenet; 2007 Oct; 178(1):61-4. PubMed ID: 17889710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AF4 and AF4-MLL mediate transcriptional elongation of 5-lipoxygenase mRNA by 1, 25-dihydroxyvitamin D3.
    Ahmad K; Scholz B; Capelo R; Schweighöfer I; Kahnt AS; Marschalek R; Steinhilber D
    Oncotarget; 2015 Sep; 6(28):25784-800. PubMed ID: 26329759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unlike Its Paralog LEDGF/p75, HRP-2 Is Dispensable for MLL-R Leukemogenesis but Important for Leukemic Cell Survival.
    Van Belle S; El Ashkar S; Čermáková K; Matthijssens F; Goossens S; Canella A; Hodges CH; Christ F; De Rijck J; Van Vlierberghe P; Veverka V; Debyser Z
    Cells; 2021 Jan; 10(1):. PubMed ID: 33477970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MLL is essential for NUP98-HOXA9-induced leukemia.
    Shima Y; Yumoto M; Katsumoto T; Kitabayashi I
    Leukemia; 2017 Oct; 31(10):2200-2210. PubMed ID: 28210005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of MLL-fusion/MYC⊣miR-26⊣TET1 signaling circuit in MLL-rearranged leukemia.
    Huang H; Jiang X; Wang J; Li Y; Song CX; Chen P; Li S; Gurbuxani S; Arnovitz S; Wang Y; Weng H; Neilly MB; He C; Li Z; Chen J
    Cancer Lett; 2016 Mar; 372(2):157-65. PubMed ID: 26791235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Instructive Role of MLL-Fusion Proteins Revealed by a Model of t(4;11) Pro-B Acute Lymphoblastic Leukemia.
    Lin S; Luo RT; Ptasinska A; Kerry J; Assi SA; Wunderlich M; Imamura T; Kaberlein JJ; Rayes A; Althoff MJ; Anastasi J; O'Brien MM; Meetei AR; Milne TA; Bonifer C; Mulloy JC; Thirman MJ
    Cancer Cell; 2016 Nov; 30(5):737-749. PubMed ID: 27846391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematopoietic transformation in the absence of MLL1/KMT2A: distinctions in target gene reactivation.
    Chen Y; Ernst P
    Cell Cycle; 2019 Jul; 18(14):1525-1531. PubMed ID: 31161857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirement for Dot1l in murine postnatal hematopoiesis and leukemogenesis by MLL translocation.
    Jo SY; Granowicz EM; Maillard I; Thomas D; Hess JL
    Blood; 2011 May; 117(18):4759-68. PubMed ID: 21398221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting MLL-AF4 with short interfering RNAs inhibits clonogenicity and engraftment of t(4;11)-positive human leukemic cells.
    Thomas M; Gessner A; Vornlocher HP; Hadwiger P; Greil J; Heidenreich O
    Blood; 2005 Nov; 106(10):3559-66. PubMed ID: 16046533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.